Select your location:

New ccfDNA data presented at the AACR meeting in Chicago show how blood stabilization affords high-quality analytes for cancer research using liquid biospies.

Date: April 14–18, 2018
Location: Chicago, Illinois, USA

Have a look at new studies presented at the AACR Annual Meeting – Driving Innovative Cancer Science to Patient Care.

Blood stabilization is key for sensitive liquid biopsy cancer research application, particularly in NGS. Thomas Krenz presented a study showing how PAXgene tubes work for the GeneReader NGS System, and how future cancer panels may benefit from it.

In case you missed it at AACR – explore the poster here:

Verification of a Complete Sample to Insight® Liquid Biopsy Workflow – NGS of ccfDNA From Stabilized Blood.
Tomasz Krenz, Andrea Ullius, Ricardo Huebel, Thorsten Voss, Eric Provencher, Timothy R. Buirkle and Daniel Groelz. PreAnalytiX GmbH, Hombrechtikon, Switzerland

Back to the news